Join
Live feed
·
INSIDERFilingvia Quantisnow
Syros Pharmaceuticals Inc. logo

Haas Jason covered exercise/tax liability with 4,732 shares and converted options into 15,333 shares, increasing direct ownership by 76% to 24,552 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track SYRS (Syros Pharmaceuticals Inc.) and more on Quantisnow.